|
Match
|
Document |
Document Title |
|
|
6585991 |
Termite bait matrix
Termite foods mixed together in a matrix suitable to be used as baits and attractants for termites are provided. This termite matrix is preferred by termites over naturally-occurring foods such as...
|
|
|
6579533 |
Bioabsorbable drug delivery system for local treatment and prevention of infections
This invention relates to bioabsorbable materials and implants used to prevent and treat infection and promote bone growth. More specifically, this invention relates to synthetic bioabsorbable drug...
|
|
|
6579536 |
Sustained-release pharmaceutical preparation containing tilidine mesylate as active ingredient
The invention relates to a solid, sustained-release pharmaceutical composition for oral administration containing tilidine mesylate as active ingredient.
|
|
|
6576260 |
Sustained-release form of administration containing tramadol saccharinate
Disclosed herein is sustained-release formulations of tramadol comprising tramadol saccharinate coated with at least one sustained-release coating. The sustained release formulations may also...
|
|
|
6576261 |
Potentiation of inclusion complex formation of cyclodextrin derivatives
A method is disclosed for the potentiation of formation of inclusion complexes of electroneutral and anionic compounds. Included are compositions containing complexes of two different cyclodextrin...
|
|
|
6576263 |
Delivery systems using preformed biodegradable polymer compositions and methods
A preformed object for delivering an active agent for a subject, the preformed object including crosslinked protein, and methods of making and using.
|
|
|
6569452 |
Pharmaceutical formulations in hydroxypropylmethylcellulose capsules
An oral pharmaceutical formulation, which comprises, in a hydroxypropylmethylcellulose capsule, a camptothecin analogue dispersed or solubilized in a semi-solid matrix of a polyethyleneglycol with...
|
|
|
6569466 |
Conditioning of bioactive glass surfaces in protein containing solutions
Conditioning of the surface of silica-based glass or ceramic by differential immersion in a serum protein-containing solution, and the resultant microporous Ca-P surface layer having serum-protein...
|
|
|
6569459 |
Method of administration of paclitaxel-plasma protein formulation
The present invention provides for a method for treating human or animal patients with paclitaxel formulation, the method comprising an intratumoral dose of a paclitaxel formulation and an...
|
|
|
6565876 |
Carnitine and inositol phosphate-containing composition useful as dietary supplement or drug
A composition is disclosed suitable for the prevention and/or treatment of cardiovascular and neurocerebral disorders, tissue anoxic forms, muscular energy deficits, inflammatory-type...
|
|
|
6565884 |
Bone graft material incorporating demineralized bone matrix and lipids
A demineralized bone putty composition comprises: (1) demineralized bone matrix (DBM); and (2) a lipid fraction selected from the group consisting of lecithin and a mixture of lecithin and...
|
|
|
6565872 |
Polymeric system for drug delivery and solute separation
Described is a composite polymeric system to provide enhanced stimuli-responsiveness. The first aspect provides particles where the particles are made of stimuli-responsive polymer which responds...
|
|
|
6565882 |
Antibiotic composition with inhibitor
Antibiotic composition having four dosage forms with different release profiles providing for initial release of a beta lactam antibiotic followed by release of a beta-lactamase inhibitor, followed...
|
|
|
6562367 |
Transdermal therapeutic system (TTS) for administering sexual steroid hormones
A transdermal therapeutic system for transcutaneous administration of sexual steroid hormones over long time periods, and a solvent-free method for the production thereof, is disclosed. The steroid...
|
|
|
6562374 |
Biodegradable porous polymer scaffolds for tissue engineering prepared from an effervescent mixture and its preparation
The present invention provides a method for preparing biodegradable porous polymer scaffolds for tissue engineering, comprising: a) fabricating a polymer sample from a polymer solution containing...
|
|
|
6558703 |
Porous hydroxyapatite particles as carriers for drug substances
A drug delivery system for oral administration in solid dry form of a greasy/oily/sticky substance and a pharmaceutically active substance or a pharmaceutically active substance which itself is...
|
|
|
6558712 |
Delivery system for pharmaceutical, nutritional and cosmetic ingredients
A stable, water-soluble delivery system of a purified Shilajit composition obtained by extraction of native Shilajit, containing at least 40% by weight of a carrier which is purified fulvic acid,...
|
|
|
6558696 |
Desoxypeganine
The invention relates to a transdermal therapeutic system (TTS) containing desoxypeganine (1,2,3,9-Tetrahydropyrrolo[2,1-b]quinazoline) as the active component, wherein the TSS includes a back...
|
|
|
6558682 |
Discontinuous films from skin care compositions
The present invention relates to substantially uniform, discontinuous films of a skin care product having a defined average particle size, particle spacing and coverage value. The films provide...
|
|
|
6558694 |
Zinc chloride unit dose packaging, applicator, and method of use in treating cancer and other skin diseases
An improved method for the treatment of melanoma and skin diseases which utilizes a zinc chloride fixative mixture is provided. The active ingredients of the fixative mixture include zinc chloride...
|
|
|
6555525 |
Microencapsulation and sustained release of oligonucleotides
This invention relates to a composition, and method of forming and using the composition, for the sustained release of oligonucleotides, in particular antisense ODNs. The sustained release...
|
|
|
6555138 |
Polyethylene glycol matrix pellets for greasy, oily or sticky drug substances
A drug delivery system for oral administration in solid dry form of greasy/oily/sticky substance(s) and pharmaceutically active substance(s) or pharmaceutically active substance(s) which...
|
|
|
6555134 |
Synergistic mixtures of garlic and lycopene for preventing LDL oxidation
The present invention provides a synergistic pharmaceutical or dietary composition containing lycopene and garlic. The present invention also provides an improved method to block the oxidation of...
|
|
|
6555129 |
Transdermal therapeutic system (TTS) containing oxybutynin
A transdermal therapeutic system (TTS) for transcutaneous administration of oxybutynin over a period of several days, in addition to a method for the production of the TTS without the use of...
|
|
|
6555131 |
Therapeutical system for transdermal delivery of levonorgestrel
A stable therapeutical transdermal system for the transcutaneous delivery of levonorgestrel, alone or together with other sex steroid hormones, over a long time period is disclosed. A method of...
|
|
|
6555137 |
Sucralfate-containing composition and process for the preparation thereof
A coated antacid comprising sucralfate and an antacid inhibits decline in the adhesion characteristics of sucralfate whereby the drug ingested can reliably show its effect in the stomach. This...
|
|
|
6552024 |
Compositions and methods for mucosal delivery
Mucosal surface-coat-forming film dosage units containing a water-soluble hydrocolloid, an effective dose of an active agent and a mucosal adhesion enhancer; wherein the active agent is...
|
|
|
6551618 |
Compositions and methods for delivery of agents for neuronal regeneration and survival
Devices useful in the delivery of DNA encoding neurotrophic agents, anti-fibrotic agents, and related compositions are disclosed herein for use in the treatment of central and/or peripheral nervous...
|
|
|
6551619 |
Pharmaceutical cyclosporin formulation with improved biopharmaceutical properties, improved physical quality and greater stability, and method for producing said formulation
The invention relates to solid, particulate lipid-based excipients which are loaded with cyclosporine. Said excipients have improved biopharmaceutical properties for cyclosporines in vivo, are of a...
|
|
|
6551612 |
Methods for modulating the axonal outgrowth of central nervous system neurons
Methods for modulating the axonal outgrowth of central nervous system neurons are provided. Methods for stimulating the axonal outgrowth of central nervous system neurons following an injury (e.g.,...
|
|
|
6548555 |
Basic drug compositions with enhanced bioavailability
A composition comprising a basic drug, a drug which forms a zwitterion, or a salt of either entity, admixed with a polymer selected from hydroxypropylmethylcellulose acetate succinate (HPMCAS),...
|
|
|
6548071 |
Lyophilizate of lipid complex of water insoluble camptothecins
A pharmaceutical composition comprising a lyophilizate of non-liposomal complex of a water insoluble camptothecin and a phospholipid, said lyophilizate additionally containing a pharmaceutically...
|
|
|
6548084 |
Controlled release compositions
A controlled release or delayed release formulation contains a selective serotonin reuptake inhibitor (SSRI) such as paroxetine.
|
|
|
6544547 |
Nutritional composition containing methionine
An enteral food composition for clinical or dietary use, comprises, in addition to carbohydrates and proteins or their hydrolysates the following components or their nutritional equivalents, per...
|
|
|
6544555 |
Antibiotic product, use and formulation thereof
An antibiotic product is comprised of at least three dosages forms, each of which has a different release profile, with the C max for the antibiotic product being reached in less than about twelve...
|
|
|
6541032 |
Use of finely divided dye-containing polymers PD as color-imparting constituent in cosmetic compositions
The present invention describes the use of finely divided dye-containing polymers PD in the form of an aqueous polymer dispersion or a polymer powder obtainable therefrom, the polymer matrix of...
|
|
|
6541026 |
Nutritional composition, methods of producing said composition and methods of using said composition
Nutritional compositions comprising aloe vera, hydrolyzed collagen, garcinia cambogia, chromium polynicotinate, chromium picolinate, chromium cruciferate, conjugated linoleic acid, fiber and...
|
|
|
6541023 |
Use of collagen of aquatic origin for the production of supports for tissue engineering, and supports and biomaterials obtained
Use of collagen of aquatic origin for the production of supports for tissue engineering is disclosed. The collagen may be obtained from fish skin, preferably in its native form. Novel tissue...
|
|
|
6541031 |
Composition with release-controlling action
The present invention relates to a composition for delayed and gentle release of active substances ( 4 ) in the body, containing a carrier material which is insoluble or of low solubility in water...
|
|
|
6541021 |
Devices and methods for pain management
The invention features devices and methods for the systemic delivery of fentanyl or a fentanyl congener (e.g., sufentanil) to treat pain. In the present invention, a drug formulation comprising...
|
|
|
6541022 |
Mineral and cellular patterning on biomaterial surfaces
Disclosed are advantageous methods for patterning and/or mineralizing biomaterial surfaces. The techniques described are particularly useful for generating three-dimensional or contoured bioimplant...
|
|
|
6537577 |
Method of prophylaxis for bovine mastitis
A method is provided for treating bovine mastitis by applying a porous strippable polymer film containing a medicament to the udders of the bovine.
|
|
|
6537575 |
Synthetic biological membrane with self organizing properties
A mixture is provided which manifests a gel phase at a temperature higher than that in which the mixture manifests a liquid phase. The mixture is a combination of a lipid, a polymer-grafted...
|
|
|
6537574 |
Soft tissue augmentation material
A permanent, biocompatible material for soft tissue augmentation. The biocompatible material comprises a matrix of smooth, round, finely divided, substantially spherical particles of a...
|
|
|
6534088 |
Fibrate-statin combinations with reduced fed-fasted effects
This invention discloses an orally administered pharmaceutical composition for the treatment of elevated levels of cholesterol and related conditions comprising a statin and fenofibrate in the form...
|
|
|
6534092 |
Method for preparing microparticles having a selected polymer molecular weight
A method for preparing microparticles having a selected polymer molecular weight. The hold time and temperature of a solution containing a nucleophilic compound and a polymer having a starting...
|
|
|
6534090 |
Oral osmotic controlled drug delivery system for a sparingly soluble drug
The present invention is for an oral osmotic controlled drug delivery system for a sparingly soluble drug comprising: a. a core comprising (i) finely particulate anhydrous carbamazepine (ii) a...
|
|
|
6531159 |
Materials eliminating cannabinoids and columns for the elimination of cannabinoids with the use of the same
The present invention provides (1) a removal material for cannabinoids present in body fluids where at least one substance from amongst substances with functional groups capable of hydrogen...
|
|
|
6528088 |
Highly flexible starch-based films
Film-forming compositions are disclosed that can comprise, on a dry solids basis, 25 to 75 percent by weight of certain starch derivatives and 25 to 75% primary external plasticizer. The starch...
|
|
|
6528073 |
Solid cosmetic composition and uses thereof
A solid composition for topical application comprising, in an aqueous phase, a gelling system comprising (i) gellan gum, (ii) at least one other hydrocolloid chosen from the group formed by xanthan...
|